Long telomeres cooperate with p53,MDM2, and p21 polymorphisms to raise pediatric solid tumor risk
- 18 June 2019
- journal article
- research article
- Published by Wiley in Pediatrics International
- Vol. 61 (8) , 759-767
Abstract
Background: While leukocyte telomere length has been linked with altered risk in adult cancer, limited information is available on its association with risk in pediatric solid tumors. We investigated the association of telomeric alterations with risk of pediatric solid tumors. We also investigated whether altered telomeres cooperated with the TP53 rs1042522, MDM2 rs2279744 and CDKN1A (p21cip1) rs1059234 single‐nucleotide polymorphisms to modify cancer risk.Methods: A total of 101 tumor patients and 202 controls were recruited for this age‐ and gender‐matched case–control study. Relative telomere length (RTL) was determined in peripheral blood leukocytes using quantitative real‐time polymerase chain reaction (PCR), and the polymorphisms were genotyped using PCR–restriction fragment length polymorphism.Results: Using median RTL in the healthy controls as a cut‐off, children with longer telomeres were at an increased risk of developing a solid tumor (OR, 2.70; P < 0.01). When participants were categorized according to control RTL quartiles, a significant dose–response relationship was observed (χ2 = 10.95; P < 0.001). The risk for tumors increased nearly threefold (P = 0.001) for the triple interaction RTL × TP53 rs1042522 × p21cip1 rs1059234 compared with the maximum effect of any single factor, although the interaction effect was less than additive. The MDM2 rs2279744 GG genotype reduced pediatric solid tumor risk significantly (OR, 0.51).Conclusion: Combined analysis of telomeres and genetic polymorphisms in the TP53 pathway can provide important clues to understanding pediatric solid tumor etiology.Keywords
This publication has 38 references indexed in Scilit:
- Epigenetic, Genetic and Environmental Interactions in Esophageal Squamous Cell Carcinoma from Northeast IndiaPLOS ONE, 2013
- A functional polymorphism T309G in MDM2 gene promoter, intensified by Helicobacter pylori lipopolysaccharide, is associated with both an increased susceptibility and poor prognosis of gastric carcinoma in Chinese patientsBMC Cancer, 2013
- The MDM2 309T>G Polymorphism and Ovarian Cancer Risk: A Meta-Analysis of 1534 Cases and 2211 ControlsPLOS ONE, 2013
- Assessing telomeric DNA content in pediatric cancers using whole-genome sequencing dataGenome Biology, 2012
- Association of Age at Diagnosis and Genetic Mutations in Patients With NeuroblastomaJAMA, 2012
- Dual Roles of MDM2 in the Regulation of p53: Ubiquitination Dependent and Ubiquitination Independent Mechanisms of MDM2 Repression of p53 ActivityGenes & Cancer, 2012
- Comprehensive Mapping of p53 Pathway Alterations Reveals an Apparent Role for Both SNP309 and MDM2 Amplification in SarcomagenesisClinical Cancer Research, 2011
- Effect of TP53 Arg72Pro and MDM2 SNP309 Polymorphisms on the Risk of High-Grade Osteosarcoma Development and SurvivalClinical Cancer Research, 2009
- Combined effects of the p53 codon 72 and p73 G4C14-to-A4T14 polymorphisms on the risk of HPV16-associated oral cancer in never-smokersCarcinogenesis, 2008
- hTERT antagonizes p53-induced apoptosis independently of telomerase activityOncogene, 2004